会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • Modulation of PDE11A activity
    • 调节PDE11A活性
    • US20060121550A1
    • 2006-06-08
    • US10137498
    • 2002-04-29
    • Martyn BurslemIan HarrowJeremy LanfearStephen PhillipsChristopher Wayman
    • Martyn BurslemIan HarrowJeremy LanfearStephen PhillipsChristopher Wayman
    • C12Q1/42A61K31/519
    • A61K31/519C12Q1/42
    • The invention provides genetically modified non-human mammals and genetically modified animal cells containing a functionally disrupted PDE11A gene. Also provided by the invention are methods of screening for agents that modulate PDE11A to modulate spermatogenesis, methods of treating mammals to modulate spermatogenesis, and methods of modulating cAMP and cGMP signal transduction in cells that express PDE11A. The invention also provides agents and methods relating to the effect of PDE11A modulation (i.e. PDE11A inhibition or stimulation) on ex vivo spermatozoa capacitation and PDE11A stimulation on in vivo spermatozoa capacitation. The invention also relates to the effect of PDE11A modulation on male pro-fertility and female sexual dysfunction (FSD), specifically female sexual arousal disorder (FSAD), female orgasmic disorder (FOD), hypoactive sexual desire disorder (HSDD) or sexual pain disorders.
    • 本发明提供了遗传修饰的非人哺乳动物和含有功能性破坏的PDE11A基因的遗传修饰的动物细胞。 本发明还提供筛选调节PDE11A以调节精子发生的药剂的方法,治疗哺乳动物以调节精子发生的方法,以及在表达PDE11A的细胞中调节cAMP和cGMP信号转导的方法。 本发明还提供了与PDE11A调节(即PDE11A抑制或刺激)对离体精子获能和PDE11A刺激对体内精子获能的影响有关的药剂和方法。 本发明还涉及PDE11A调节对男性生殖能力和女性性功能障碍(FSD),特别是女性性唤起障碍(FSAD),女性高潮症(FOD),低反应性欲欲障碍(HSDD)或性疼痛障碍 。